Mark Levin
Oprichter bij The Possible Project, Inc.
Oorsprong van het eerstegraads netwerk van Mark Levin
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
National Academy of Engineering
National Academy of Engineering Miscellaneous Commercial ServicesCommercial Services Part of The National Academies of Science, the National Academy of Engineering operates as a professional membership organization. The private company is based in Washington.
324
| Subsidiary | Miscellaneous Commercial Services | 324 |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts.
120
| Private Company | Investment Managers | 120 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA.
108
| Subsidiary | Pharmaceuticals: Major | 108 |
Partners In Health
Partners In Health Miscellaneous Commercial ServicesCommercial Services Partners In Health provides healthcare facilities for the poor. It has operations in Haiti, Rwanda, Peru, Russia, the USA, Malawi, and Lesotho. The company was founded by Ophelia Dahl, Paul Farmer, Jim Yong Kim, Todd McCormack and Tom White in 1987 and is headquartered in Boston, MA.
86
| Non-Profit Organization | Miscellaneous Commercial Services | 86 |
Public Company | Biotechnology | 39 | |
Subsidiary | Medical/Nursing Services | 22 | |
Extinct | Pharmaceuticals: Major | 20 | |
Personalized Medicine Coalition
Personalized Medicine Coalition Miscellaneous Commercial ServicesCommercial Services The Personalized Medicine Coalition promotes the understanding and adoption of personalized medicine concepts, services, and products. The private company is based in Washington and was founded by Patrick F. Terry.
15
| Private Company | Miscellaneous Commercial Services | 15 |
NinePoint Medical, Inc.
NinePoint Medical, Inc. Medical SpecialtiesHealth Technology NinePoint Medical, Inc. develops and manufactures medical devices. It designs, manufactures, and sells an Optical Coherence Tomography (OCT) imaging platform for clinical use in gastroenterology, pulmonology, urology, gynecology, evaluation of human tissue microstructure. The company is headquartered in Bedford, MA.
10
| Holding Company | Medical Specialties | 10 |
Corvia Medical, Inc.
Corvia Medical, Inc. Medical SpecialtiesHealth Technology Corvia Medical, Inc. develops medical devices for the treatment of heart failure. It also offers transcatheter treatment of heart failure with preserved or mildly reduced ejection fraction. The company was founded by David S. Celermajer and is headquartered in Tewksbury, MA.
9
| Holding Company | Medical Specialties | 9 |
Abgenix, Inc.
Abgenix, Inc. BiotechnologyHealth Technology Abgenix, Inc. developed therapeutic products. It focused on the discovery, development and manufacturing of therapeutic antibodies. The firm's antibody development platform included manufacturing fully human antibody product candidates to a variety of disease targets. The company was founded by R. Scott Greer in 1996 and was headquartered in Fremont, CA.
8
| Extinct | Biotechnology | 8 |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA.
4
| Extinct | Miscellaneous Commercial Services | 4 |
Cell Genesys, Inc.
Cell Genesys, Inc. Pharmaceuticals: MajorHealth Technology Cell Genesys is a development-stage biotechnology firm focuses on gene-modification technologies to treat cancer. The company's lead product technology is its GVAX vaccine platform. Cell Genesys is working on GVAX vaccines for lung, prostate, and pancreatic cancer, as well as for leukemia and multiple myeloma, another blood cancer. Its oncolytic viral therapy platform uses specially engineered adenoviruses (such as the common cold) to kill cancer cells; the firm's lead candidate from this platform targets prostate cancer.
4
| Extinct | Pharmaceuticals: Major | 4 |
Focal, Inc.
Focal, Inc. Chemicals: SpecialtyProcess Industries Focal Inc, is a developing biodegradable interventional therapeutic products to treat serious local diseases. The company products consist of a biodegradable polymer system that can deliver drugs locally to the site of disease and/or act as a physical barrier. Other Focal research & development programs include polymer and drug delivery products to: prevent adhesions (internal scar tissue) following surgery; serve as surgical sealants; and deliver drugs locally for other indications.
4
| Extinct | Chemicals: Specialty | 4 |
CytoTherapuetics, Inc.
4
| Extinct | Financial Conglomerates | 4 |
Mayfield Fund LLC
Mayfield Fund LLC Investment ManagersFinance Mayfield Fund LLC (Mayfield Fund) is a venture capital firm founded in 1969 by Mark Jay Levin. The firm is headquartered in Menlo Park, California.
3
| Private Company | Investment Managers | 3 |
The Possible Project, Inc.
3
| Non-Profit Organization | 3 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Mark Levin via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Massachusetts Institute of Technology | College/University | Doctorate Degree Director/Board Member Graduate Degree Corporate Officer/Principal Doctorate Degree Director/Board Member Corporate Officer/Principal Graduate Degree Corporate Officer/Principal Doctorate Degree Doctorate Degree Graduate Degree Doctorate Degree | |
Harvard Medical School | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Operating Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Human Resources Officer | |
BLUEBIRD BIO, INC. | Biotechnology | Director/Board Member Director/Board Member Chairman Director/Board Member Director/Board Member Chief Operating Officer | |
American Academy of Arts & Sciences
American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services The American Academy of Arts & Sciences is an organization that honors excellence and brings together leaders. The non-profit company is based in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal Doctorate Degree Undergraduate Degree Doctorate Degree | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Director of Finance/CFO Corporate Officer/Principal | |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Chairman Director/Board Member Director/Board Member Corporate Secretary Director/Board Member | |
CONSTELLATION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member Director/Board Member Corporate Officer/Principal | |
National Academy of Sciences
National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services National Academy of Sciences operates as a private, nongovernmental institution that advises on issues related to science and technology. It provides independent, objective analysis and advice and conducts other activities to solve complex problems and inform public policy decisions. The firm also encourages education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science. The company was founded on March 3, 1863 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Thrive Earlier Detection Corp.
Thrive Earlier Detection Corp. Medical SpecialtiesHealth Technology Thrive Earlier Detection Corp. operates as a healthcare company. It focuses on incorporating earlier cancer detection into routine medical care. The company was founded by Bert Vogelstein, Kenneth W. Kinzler, Isaac Kinde, Christoph S. Lengauer, and Nickolas Papadopoulos in 2019 and is headquartered in Cambridge, MA. | Medical Specialties | Director/Board Member Director/Board Member Chief Executive Officer Director/Board Member Director/Board Member | |
The Trustees of Columbia University in The City of New York | College/University | Graduate Degree Corporate Officer/Principal Undergraduate Degree Corporate Officer/Principal | |
Stanford University | College/University | Corporate Officer/Principal Graduate Degree Undergraduate Degree Undergraduate Degree | |
National Academy of Medicine (United States)
National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
University of California San Diego | College/University | Undergraduate Degree Corporate Officer/Principal Corporate Officer/Principal Undergraduate Degree | |
Boston College | College/University | Graduate Degree Corporate Officer/Principal Undergraduate Degree Undergraduate Degree | |
NEON THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member Chief Executive Officer | |
University of Virginia | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
BIOGEN INC. | Pharmaceuticals: Major | Director/Board Member Chairman Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
JOUNCE THERAPEUTICS, INC. | Miscellaneous Commercial Services | Chairman Chief Tech/Sci/R&D Officer Director/Board Member Chief Executive Officer | |
Duke University
Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Graduate Degree Undergraduate Degree Director/Board Member Doctorate Degree | |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Edimer Pharmaceuticals, Inc.
Edimer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Edimer Pharmaceuticals, Inc. provides biopharmaceutical products for improving the health and quality of life of families living with XLHED. It has developed EDI200 as a treatment for X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), which is a rare orphan disease that causes symptoms including lack of sweat glands, poor temperature control, respiratory problems, and hair and tooth malformations. The company was founded by Pascal Schneider and Olivier Gaide in 2009 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
DECIBEL THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Director/Board Member Chief Executive Officer | |
Virginia Polytechnic Institute & State University | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree | |
ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Medical Specialties | Corporate Officer/Principal Director/Board Member Director/Board Member | |
Casma Therapeutics, Inc.
Casma Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Casma Therapeutics, Inc. operates biotechnology company harnessing natural cellular process of autophagy to design new medicines. The company was founded by Cary Pfeffer and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Founder Founder Founder | |
University of Cambridge | College/University | Doctorate Degree Undergraduate Degree Graduate Degree | |
PLIANT THERAPEUTICS, INC. | Biotechnology | Chairman Director/Board Member Director/Board Member | |
Princeton University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing Director of Finance/CFO | |
University of Pennsylvania | College/University | Undergraduate Degree Graduate Degree Doctorate Degree | |
Section 32 LLC
Section 32 LLC Investment ManagersFinance Section 32 LLC (Section 32) is a venture capital firm founded in 2017 by Bill Maris. The firm is headquartered in Silicon Valley, California. | Investment Managers | Private Equity Investor Private Equity Investor Consultant / Advisor | |
AGIOS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Chief Executive Officer | |
Tango Therapeutics Sub, Inc.
Tango Therapeutics Sub, Inc. BiotechnologyHealth Technology Tango Therapeutics, Inc. develops transformational new drugs for cancer patients. The company was founded by Alan Ashworth, Jos? Baselga, Levi Garraway, Timothy K. Lu, Antoni Ribas and William G. Kaelin, Jr. in 2017 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Flare Therapeutics, Inc.
Flare Therapeutics, Inc. BiotechnologyHealth Technology Flare Therapeutics is a biotechnology company that focuses on drugging transcription factors to develop small molecule medicines. The company is based in Cambridge, MA. The company's integrated discovery engine converges genetic, biochemical, and chemical insights to reveal druggable pockets and identify small molecule ligands capable of modulating transcription factors of high therapeutic potential. Flare's proteomic and mass spectrometry platform is powered by a proprietary library of electrophilic compounds unique to the company. The team has rapidly established an emerging pipeline of programs, highlighted by FX-909, a first-in-class investigational orally bioavailable small molecule inhibitor of PPARG, a master regulator of the luminal lineage in advanced urothelial cancer that has entered the clinic. Flare Therapeutics was launched in 2021 and is backed by founding investor Third Rock Ventures, as well as Boxer Capital, Nextech Invest, Casdin Capital, Invus Financial Advisors, and Eventide Asset Management. The company was founded by Mitchell Lazar, Fraydoon Rastinejad, Robert J. Sims, and Steven L. McKnight. Amit Rakhit has been the CEO of the company since 2022. | Biotechnology | Director/Board Member Chairman Founder | |
University of California, Los Angeles | College/University | Graduate Degree Corporate Officer/Principal Corporate Officer/Principal | |
BLUEPRINT MEDICINES CORPORATION | Biotechnology | Chairman Director/Board Member Corporate Officer/Principal | |
Yale University | College/University | Undergraduate Degree Corporate Officer/Principal Undergraduate Degree | |
The University of California, San Francisco | College/University | Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
GLOBAL BLOOD THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder Director/Board Member Director/Board Member | |
University of Oxford | College/University | Doctorate Degree Doctorate Degree Graduate Degree | |
Rheos Medicines, Inc.
Rheos Medicines, Inc. BiotechnologyHealth Technology Rheos Medicines, Inc. operates as a biopharmaceutical firm. It develops novel medicines that modulate metabolic pathways in immune cells to treat disease. The company was founded by Erika Pearce, Edward Pearce, Laurence Turka, Richard Flavell, Ken Smith, and E. William St. Clair and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Chairman Director/Board Member | |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Biotechnology | Comptroller/Controller/Auditor Corporate Officer/Principal | |
Purdue University | College/University | Undergraduate Degree Corporate Officer/Principal | |
ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Vineti, Inc.
Vineti, Inc. Medical/Nursing ServicesHealth Services Vineti, Inc. develops software for scaling and digital solutions for cell and gene therapies. The firm focuses on enabling life changing autologous therapies, supporting standards, and developing infrastructure that will expand patient access through expedited discovery, delivery and regulation in the field. The company was founded by Heidi Hagen, Malek Faham, Amy DuRoss and Razmik Abnous and is headquartered in San Francisco CA. | Medical/Nursing Services | Director/Board Member Director/Board Member |
Statistieken
Internationaal
Verenigde Staten | 48 |
Verenigd Koninkrijk | 3 |
Zwitserland | 2 |
Sectoraal
Health Technology | 24 |
Consumer Services | 19 |
Commercial Services | 7 |
Finance | 3 |
Health Services | 2 |
Operationeel
Director/Board Member | 741 |
Corporate Officer/Principal | 345 |
Independent Dir/Board Member | 206 |
Chairman | 150 |
Chief Executive Officer | 95 |
Sterkste connecties
Insiders | |
---|---|
Kiran Mazumdar-Shaw | 66 |
Ursula Burns | 52 |
Steven Paul | 38 |
Perry Karsen | 38 |
Neil Exter | 33 |
Daniel Lynch | 32 |
William Young | 32 |
Michael Pellini | 31 |
Russell C. Hirsch | 31 |
Jerson Kelman | 29 |
Charles Homcy | 28 |
David Goeddel | 27 |
Stephen Sherwin | 26 |
Wendy Dixon | 25 |
James Geraghty | 25 |
- Beurs
- Insiders
- Mark Levin
- Bedrijfsconnecties